[Direct involvement of the supraspinal phosphoinositide 3-kinase/phospholipase C gamma 1 pathway in the mu-opioid receptor agonist-induced supraspinal antinociception in the mouse]
- PMID: 12884752
[Direct involvement of the supraspinal phosphoinositide 3-kinase/phospholipase C gamma 1 pathway in the mu-opioid receptor agonist-induced supraspinal antinociception in the mouse]
Abstract
Recent works have documented that the stimulation of the mu-opioid receptor (MOR) can activate phosphoinositide-specific phospholipase C (PI-PLC). Here I demonstrate that PLC beta 3 isoform activated by beta gamma subunit of G-protein (G beta gamma) in the brain may contribute to the negative modulation for supraspinal antinociception induced by morphine in mice. In immunohistochemical studies, phosphoinositide 3-kinase (PI3K) was detected in the membrane of the cell soma and the immunoreactivity of PI3K (PI3K-IR) was almost overlapped with MOR-IR and PLC gamma 1-IR in the periaqueductal gray matter (PAG) that is considered to be one of the most important sites for the expression of MOR-mediated antinociception. Morphine produced a marked increase in the protein level of membrane-bound PLC gamma 1, and this increase induced by morphine was significantly inhibited by intracerebroventricullar (i.c.v.) pretreatment with PI3K inhibitors at the dosage that suppressed the morphine-induced supraspinal antinociception. Furthermore, morphine also caused a robust increase in the number of phosphorylated-PLC gamma 1 (p-PLC gamma 1) expressing cells in the PAG. It is worthwhile to note that MOR-IR was overlapped with p-PLC gamma 1-IR in the same cells that also contained PI3K in this region. Based on these findings, the next experiment was designed to investigate whether a deletion of the PLC gamma 1 gene by i.c.v. pretreatment with antisense oligodeoxynucleotide (AS-ODN) against PLC gamma 1 could affect the antinociception induced by MOR agonists. Pretreatment with AS-ODN against PLC gamma 1 revealed a significant inhibition of supraspinal antinociception induced by MOR-agonists. In addition, the morphine-induced supraspinal antinociception was suppressed by the blockade of the G beta gamma subunit that can directly activate both PI3K and PLC gamma 1. Moreover, mice lacking the gene for inositol 1,4,5-trisphosphate (IP3)-sensitive receptors, which can modulate the release of Ca2+ from the endoplasmic reticulum, exhibited a significant inhibition of the morphine-induced antinociception. Collectively, these findings raise the possibility that the activation of the PLC pathway associated with the stimulation of PI3K and/or G beta gamma is implicated in supraspinal antinociception induced by MOR agonists in mice.
Similar articles
-
Increased level of neuronal phosphoinositide 3-kinase gamma by the activation of mu-opioid receptor in the mouse periaqueductal gray matter: further evidence for the implication in morphine-induced antinociception.Neuroscience. 2004;124(3):515-21. doi: 10.1016/j.neuroscience.2003.11.023. Neuroscience. 2004. PMID: 14980723
-
[The involvement of phosphoinositide 3-kinase (PI3-Kinase) and phospholipase C gamma (PLC gamma) pathway in the morphine-induced supraspinal antinociception in the mouse].Nihon Shinkei Seishin Yakurigaku Zasshi. 2001 Feb;21(1):7-14. Nihon Shinkei Seishin Yakurigaku Zasshi. 2001. PMID: 11400324 Japanese.
-
Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.J Pharmacol Exp Ther. 1996 Oct;279(1):39-46. J Pharmacol Exp Ther. 1996. PMID: 8858973
-
Novel mechanisms for feedback regulation of phospholipase C-beta activity.IUBMB Life. 2002 Nov;54(5):253-60. doi: 10.1080/15216540215673. IUBMB Life. 2002. PMID: 12587975 Review.
-
Opioid μ-receptors as new target for insulin resistance.Pharmacol Ther. 2013 Sep;139(3):334-40. doi: 10.1016/j.pharmthera.2013.05.002. Epub 2013 May 18. Pharmacol Ther. 2013. PMID: 23688574 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous